Form 4: NeueHealth CEO Mikan Reports Ownership Change Post-Merger

George Lawrence Mikan III, CEO and President of NeueHealth, Inc., reported changes in his beneficial ownership following the company's acquisition by NH Holdings 2025, Inc.

Summary

• George Lawrence Mikan III, CEO and President of NeueHealth, Inc. (NEUE), reported changes in his beneficial ownership.
• The changes occurred on October 2, 2025, as a result of NH Holdings 2025, Inc. ("Parent") acquiring NeueHealth, Inc. through a merger.
• NeueHealth, Inc. merged with a subsidiary of Parent, surviving as a wholly-owned subsidiary.
• Mikan contributed his shares of NeueHealth common stock, Series A Preferred Stock, and Series B Preferred Stock to NH Holdings 2025 SPV, L.P. ("Holdings").
• In exchange, Mikan received Holdings common units, series A preferred units, and series B preferred units on a one-for-one basis.
• Outstanding restricted stock units (RSUs) for NeueHealth common stock were assumed and adjusted into RSUs for common stock of Parent, retaining the original vesting terms.

Sentiment

Score: 5

Explanation: The filing is a factual report of a change in beneficial ownership due to a corporate merger, providing no direct positive or negative financial performance indicators for the issuer. The continuity of RSU terms is a neutral outcome for the insider.

Positives

• The continuity of vesting terms for restricted stock units (RSUs) ensures that the incentive structure for the reporting person remains intact post-merger, now tied to the acquiring entity.

Negatives

• The disposition of all common stock and restricted stock units of NeueHealth, Inc. by the reporting person signifies the end of direct equity ownership in the publicly traded entity, as it became a wholly-owned subsidiary.

Risks

• The change in ownership structure, with NeueHealth becoming a wholly-owned subsidiary of NH Holdings 2025, Inc., could lead to shifts in strategic direction or operational priorities under the new parent company.
• The indirect control by private investment funds affiliated with New Enterprise Associates, Inc. introduces a new ownership dynamic, which may prioritize different objectives compared to a publicly traded entity.

Future Outlook

All outstanding restricted stock units of NeueHealth, Inc. were assumed and adjusted into restricted stock units of the acquiring Parent company, NH Holdings 2025, Inc., and will continue to be subject to their original vesting terms and restrictions.

Industry Context

The acquisition of NeueHealth, Inc. by NH Holdings 2025, Inc., which is indirectly controlled by private investment funds, reflects a broader trend of private equity firms acquiring public companies, particularly in the healthcare sector, to pursue long-term strategic objectives away from public market pressures.

Corporate Governance

Related Party Transactions

• The Rollover Agreement, dated September 17, 2025, involved the Reporting Person (George Lawrence Mikan III, CEO & President) contributing his shares and preferred stock of the Issuer to Holdings in exchange for Holdings units. This transaction is integral to the merger and involves a key executive.

Stakeholder Impact

• **Shareholders:** Existing public shareholders of NeueHealth, Inc. would have received consideration for their shares as part of the merger, leading to the delisting of the company.
• **Employees (with RSUs):** Employees holding restricted stock units, including the reporting person, will have their RSUs converted to units of the Parent company, maintaining their equity incentives under the new ownership structure.
• **Management:** The CEO and President, George Lawrence Mikan III, has transitioned his equity holdings from the former public entity to the new private parent company, aligning his incentives with the new ownership.

Next Steps

• Continued vesting of the adjusted restricted stock units under the terms of the Parent company's equity plans.

Key Dates

Keywords

NeueHealth, NEUE, Merger, Acquisition, Form 4, Insider Transaction, Beneficial Ownership, Restricted Stock Units, Rollover Agreement, George Lawrence Mikan III, Corporate Governance, Private Equity